{"id":"https://openalex.org/W7095994832","doi":null,"title":"Themed Issue: Drug Addiction- From Basic Research to Therapies","display_name":"Themed Issue: Drug Addiction- From Basic Research to Therapies","alternate_titles":[],"publication_year":null,"publication_date":null,"ids":{"openalex":"https://openalex.org/W7095994832"},"language":"en","primary_location":{"id":"pmh:oai:CiteSeerX.psu:10.1.1.663.4711","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.663.4711","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2751437/pdf/12248_2008_Article_81174.pdf?origin%3Dpublication_detail","raw_type":"text"},"parent_works":[],"lineage":["https://openalex.org/W7095994832"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5086474862","display_name":"Rao S. Rapaka","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rao Rapaka","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062174660","display_name":"Wolfgang Sad\u00e9e","orcid":"https://orcid.org/0000-0003-1894-6374","observed_orcids":["https://orcid.org/0000-0003-1894-6374"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Wolfgang Sad\u00e9e","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086913048","display_name":"Joni L. Rutter","orcid":"https://orcid.org/0000-0002-6502-2361","observed_orcids":["https://orcid.org/0000-0002-6502-2361"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joni L. Rutter","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"A Bstract","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A Bstract","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"reviewed_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":true,"primary_topic":{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9448000192642212,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.9448000192642212,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10056","display_name":"Neurotransmitter Receptor Influence on Behavior","score":0.02329999953508377,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10261","display_name":"Genetic Associations and Epidemiology","score":0.017000000923871994,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pharmacogenetics","display_name":"pharmacogenetics","score":0.875},{"id":"https://openalex.org/keywords/pharmacogenomics","display_name":"pharmacogenomics","score":0.9929999709129333},{"id":"https://openalex.org/keywords/drug-addiction","display_name":"drug addiction","score":0.9850000143051147},{"id":"https://openalex.org/keywords/drug-abuse","display_name":"drug abuse","score":0.7910000085830688},{"id":"https://openalex.org/keywords/drug-induced-adverse-events","display_name":"drug-induced adverse events","score":0.7680000066757202},{"id":"https://openalex.org/keywords/single-nucleotide-polymorphisms","display_name":"single nucleotide polymorphisms","score":0.7990000247955322},{"id":"https://openalex.org/keywords/addiction-treatment","display_name":"addiction treatment","score":0.6639999747276306},{"id":"https://openalex.org/keywords/mental-disorders","display_name":"mental illness","score":0.640999972820282}],"concepts":[{"id":"https://openalex.org/C55775858","wikidata":"https://www.wikidata.org/wiki/Q1152227","display_name":"Pharmacogenetics","level":4,"score":0.8403000235557556},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7038999795913696},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6927000284194946},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.5582000017166138},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5092999935150146},{"id":"https://openalex.org/C500440147","wikidata":"https://www.wikidata.org/wiki/Q701216","display_name":"Pharmacotherapy","level":2,"score":0.4702000021934509},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.398499995470047},{"id":"https://openalex.org/C2780707294","wikidata":"https://www.wikidata.org/wiki/Q27795853","display_name":"Effi","level":2,"score":0.3903999924659729},{"id":"https://openalex.org/C40010229","wikidata":"https://www.wikidata.org/wiki/Q3184856","display_name":"Substance abuse","level":2,"score":0.3804999887943268},{"id":"https://openalex.org/C2994119904","wikidata":"https://www.wikidata.org/wiki/Q1251001","display_name":"Drug response","level":3,"score":0.37860000133514404},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3531999886035919},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.33320000767707825},{"id":"https://openalex.org/C106208931","wikidata":"https://www.wikidata.org/wiki/Q1098876","display_name":"Genome-wide association study","level":5,"score":0.3237999975681305},{"id":"https://openalex.org/C2779369099","wikidata":"https://www.wikidata.org/wiki/Q3706669","display_name":"Psychoactive drug","level":3,"score":0.3122999966144562},{"id":"https://openalex.org/C139275648","wikidata":"https://www.wikidata.org/wiki/Q17134011","display_name":"SNP","level":5,"score":0.30480000376701355},{"id":"https://openalex.org/C170734499","wikidata":"https://www.wikidata.org/wiki/Q1152227","display_name":"Pharmacogenomics","level":2,"score":0.3043999969959259},{"id":"https://openalex.org/C163763905","wikidata":"https://www.wikidata.org/wiki/Q17075943","display_name":"Precision medicine","level":2,"score":0.30390000343322754},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.30239999294281006},{"id":"https://openalex.org/C2986762682","wikidata":"https://www.wikidata.org/wiki/Q964754","display_name":"Basic research","level":2,"score":0.30149999260902405},{"id":"https://openalex.org/C2986900798","wikidata":"https://www.wikidata.org/wiki/Q5308926","display_name":"Drug treatment","level":2,"score":0.2797999978065491},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.27390000224113464},{"id":"https://openalex.org/C2780673598","wikidata":"https://www.wikidata.org/wiki/Q285223","display_name":"Genetic testing","level":2,"score":0.26919999718666077},{"id":"https://openalex.org/C186413461","wikidata":"https://www.wikidata.org/wiki/Q744727","display_name":"Genetic association","level":5,"score":0.26840001344680786},{"id":"https://openalex.org/C189206191","wikidata":"https://www.wikidata.org/wiki/Q222046","display_name":"Genomics","level":4,"score":0.2531000077724457},{"id":"https://openalex.org/C12713177","wikidata":"https://www.wikidata.org/wiki/Q1900281","display_name":"Perspective (graphical)","level":2,"score":0.2502000033855438}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:CiteSeerX.psu:10.1.1.663.4711","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.663.4711","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2751437/pdf/12248_2008_Article_81174.pdf?origin%3Dpublication_detail","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4255734790","https://openalex.org/W1839698594","https://openalex.org/W2911759802","https://openalex.org/W2611749639","https://openalex.org/W2461085293","https://openalex.org/W1508047865","https://openalex.org/W4297999021","https://openalex.org/W3042876826","https://openalex.org/W2070202070","https://openalex.org/W4246664371"],"abstract_inverted_index":{"Pharmacogenetics/pharmacogenomics":[0],"is":[1,25],"the":[2,10,37,72,103,110],"study":[3],"of":[4,12,44,75,102,109,150],"how":[5],"genetic":[6,42,68],"variation":[7],"affects":[8],"pharmacology,":[9],"use":[11],"drugs":[13],"to":[14,27,30,40,96,119],"treat":[15],"disease.":[16],"When":[17],"drug":[18,46,48,97,138,151],"responses":[19],"are":[20,116],"predicted":[21],"in":[22,77,137],"advance,":[23],"it":[24],"easier":[26],"tailor":[28],"medications":[29],"different":[31],"diseases":[32],"and":[33,51,66,100,113,132,148],"individuals.":[34],"Pharmacogenetics":[35],"provides":[36],"tools":[38],"required":[39],"identify":[41],"predictors":[43],"probable":[45],"response,":[47],"effi":[49,98],"cacy,":[50,99],"drug-induced":[52],"adverse":[53,92],"events":[54],"\u2014":[55],"identifi":[56,133],"cations":[57],"that":[58,141],"would":[59],"ideally":[60],"precede":[61],"treatment":[62,125,149],"decisions.":[63],"Drug":[64],"abuse":[65,139,152],"addiction":[67],"data":[69],"have":[70,83,120],"advanced":[71],"fi":[73,81],"eld":[74],"pharmacogenetics":[76,118],"general.":[78],"Although":[79],"major":[80],"ndings":[82],"emerged,":[84],"pharmacotherapy":[85],"remains":[86],"hindered":[87],"by":[88],"issues":[89],"such":[90],"as":[91],"events,":[93],"time":[94],"lag":[95],"heterogene-ity":[101],"disorders":[104],"being":[105],"treated.":[106],"The":[107],"sequencing":[108],"human":[111],"genome":[112],"high-throughput":[114],"technologies":[115],"enabling":[117],"greater":[121],"infl":[122],"uence":[123],"on":[124],"approaches.":[126],"This":[127],"review":[128],"highlights":[129],"key":[130],"studies":[131],"es":[134],"important":[135],"genes":[136],"pharmacoge-netics":[140],"provide":[142],"a":[143],"basis":[144],"for":[145],"better":[146],"diagnosis":[147],"disorders.":[153],"K":[154],"EYWORDS:":[155],"Pharmacogenomics,":[156],"addiction,":[157],"treatment,":[158],"psychiatric":[159],"disease,":[160],"SNP":[161]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7095994832","counts_by_year":[],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2025-10-27T00:00:00"}
